Exome Asset Management as of June 30, 2026
Portfolio Holdings for Exome Asset Management
Exome Asset Management holds 52 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Guardant Health (GH) | 6.2 | $10M | 68k | 150.03 | |
| Praxis Precision Medicines I Com New (PRAX) | 5.6 | $9.1M | 27k | 334.79 | |
| Tg Therapeutics (TGTX) | 5.6 | $9.1M | 165k | 54.94 | |
| Cogent Biosciences (COGT) | 5.0 | $8.1M | 211k | 38.70 | |
| Ionis Pharmaceuticals (IONS) | 4.3 | $7.0M | 88k | 79.29 | |
| Eli Lilly & Co. (LLY) | 4.1 | $6.6M | 5.5k | 1199.43 | |
| Abivax Sa Sponsored Ads (ABVX) | 3.9 | $6.2M | 47k | 133.26 | |
| Alumis (ALMS) | 3.5 | $5.8M | 204k | 28.14 | |
| Cytokinetics Com New (CYTK) | 3.2 | $5.1M | 60k | 85.19 | |
| Enliven Therapeutics (ELVN) | 3.1 | $5.1M | 100k | 50.75 | |
| Vera Therapeutics Cl A (VERA) | 2.6 | $4.2M | 97k | 42.91 | |
| UnitedHealth (UNH) | 2.5 | $4.0M | 9.6k | 415.63 | |
| 10x Genomics Cl A Com (TXG) | 2.4 | $3.9M | 103k | 38.34 | |
| Natera (NTRA) | 2.3 | $3.7M | 14k | 271.45 | |
| Uniqure Nv SHS (QURE) | 2.3 | $3.7M | 81k | 46.06 | |
| Rhythm Pharmaceuticals (RYTM) | 2.2 | $3.6M | 32k | 111.03 | |
| Maze Therapeatics (MAZE) | 2.1 | $3.4M | 115k | 29.84 | |
| Monte Rosa Therapeutics (GLUE) | 2.0 | $3.3M | 137k | 24.20 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 2.0 | $3.2M | 167k | 19.47 | |
| Alkermes SHS (ALKS) | 2.0 | $3.2M | 61k | 52.40 | |
| Liquidia Corporation Com New (LQDA) | 1.9 | $3.1M | 39k | 79.73 | |
| United Therapeutics Corporation (UTHR) | 1.8 | $2.9M | 5.4k | 541.83 | |
| Glaukos (GKOS) | 1.7 | $2.8M | 20k | 139.76 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.6 | $2.6M | 32k | 81.51 | |
| Agios Pharmaceuticals (AGIO) | 1.6 | $2.6M | 71k | 37.11 | |
| Crescent Biopharma (CBIO) | 1.4 | $2.3M | 128k | 18.00 | |
| Astrazeneca Ord (AZN) | 1.4 | $2.3M | 12k | 187.14 | |
| Boston Scientific Corporation (BSX) | 1.3 | $2.1M | 48k | 42.68 | |
| Adagene Ads (ADAG) | 1.3 | $2.1M | 488k | 4.20 | |
| Penumbra (PEN) | 1.2 | $2.0M | 6.3k | 315.75 | |
| Intuitive Surgical Com New (ISRG) | 1.2 | $2.0M | 4.9k | 397.68 | |
| Viking Therapeutics (VKTX) | 1.2 | $1.9M | 48k | 39.01 | |
| Ocular Therapeutix (OCUL) | 1.1 | $1.8M | 182k | 9.82 | |
| Equillium (EQ) | 1.1 | $1.8M | 553k | 3.20 | |
| Ascendis Pharma A/s Ord Shs (ASND) | 1.1 | $1.8M | 6.6k | 266.72 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.1 | $1.7M | 185k | 9.38 | |
| Cytomx Therapeutics (CTMX) | 1.1 | $1.7M | 460k | 3.75 | |
| Verastem Com New (VSTM) | 1.0 | $1.6M | 429k | 3.82 | |
| Nektar Therapeutics Com New (NKTR) | 1.0 | $1.6M | 22k | 69.81 | |
| Clearpoint Neuro (CLPT) | 0.9 | $1.5M | 84k | 17.84 | |
| Insmed Com Par $.01 (INSM) | 0.9 | $1.5M | 14k | 106.62 | |
| Caris Life Sciences (CAI) | 0.9 | $1.4M | 78k | 17.82 | |
| Bridgebio Pharma (BBIO) | 0.8 | $1.4M | 18k | 74.48 | |
| Zenas Biopharma (ZBIO) | 0.8 | $1.3M | 52k | 25.38 | |
| Novabridge Biosciences Sponsored Ads (NBP) | 0.7 | $1.1M | 577k | 1.95 | |
| Establishment Labs Holdings Ord (ESTA) | 0.7 | $1.1M | 13k | 85.81 | |
| Relay Therapeutics (RLAY) | 0.5 | $889k | 48k | 18.71 | |
| Geron Corporation (GERN) | 0.5 | $799k | 624k | 1.28 | |
| Bright Minds Biosciences Com New (DRUG) | 0.4 | $710k | 10k | 70.20 | |
| Compass Therapeutics (CMPX) | 0.4 | $605k | 276k | 2.19 | |
| Replimune Group (REPL) | 0.3 | $447k | 40k | 11.07 | |
| Arbutus Biopharma (ABUS) | 0.1 | $241k | 50k | 4.80 |
